Jean-Yves Blay

Director/Board Member at TRANSGENE

63 year

Health Technology

Commercial Services

Consumer Services

Profile

Jean-Yves Blay is currently an Independent Director at Transgene SA since 2022 and General Director at Centre Léon Bérard Lyon et Rhône-Alpes since 2014.
Former positions include Independent Member-Supervisory Board at Innate Pharma SA from 2017 to 2025, President of the European Organisation for Research & Treatment of Cancer from 2009 to 2012, Secretary of the Oncology Commission at Académie Nationale de Médecine FCP, and President of UNICANCER from 2019 to 2022.
Education includes a doctorate from Université Claude Bernard Lyon 1, conferred in 1994.

Jean-Yves Blay active positions

Companies	Position	Start
TRANSGENE	Director/Board Member	2022-05-24
Centre Léon Bérard Lyon et Rhône-Alpes	Chief Executive Officer	2013-12-31

All active positions of Jean-Yves Blay

Former positions of Jean-Yves Blay

Companies	Position	End
INNATE PHARMA	Director/Board Member	2025-05-21
UNICANCER UNICANCER Hospital/Nursing ManagementHealth Services Operates as cancer center	President	2021-12-31
European Organisation for Research & Treatment of Cancer European Organisation for Research & Treatment of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as non-profit cancer research organization	President	2011-12-31
Académie Nationale de Médecine FCP Académie Nationale de Médecine FCP Miscellaneous Commercial ServicesCommercial Services Operates as professional organization for medicine	Corporate Officer/Principal	-

See the detail of Jean-Yves Blay's experience

Training of Jean-Yves Blay

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jean-Yves Blay's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Transgene SA Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer	Health Technology
Innate Pharma SA Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes	Health Technology
Université Claude Bernard Lyon 1 Université Claude Bernard Lyon 1 Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Centre Léon Bérard Lyon et Rhône-Alpes
European Organisation for Research & Treatment of Cancer European Organisation for Research & Treatment of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as non-profit cancer research organization	Commercial Services
Académie Nationale de Médecine FCP Académie Nationale de Médecine FCP Miscellaneous Commercial ServicesCommercial Services Operates as professional organization for medicine	Commercial Services
UNICANCER UNICANCER Hospital/Nursing ManagementHealth Services Operates as cancer center	Health Services